These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29744719)
1. An Exercise in Clinical Reasoning: Do You Unpack? Watkins S; Gaffo AL; Clark AV; Steinhilber S J Gen Intern Med; 2018 Jul; 33(7):1196-1200. PubMed ID: 29744719 [No Abstract] [Full Text] [Related]
2. Low-dose interferon alfa-2a therapy in severe uveitis associated with Behçet disease. Onal S; Kazokoglu H; Direskeneli H; Yavuz S Am J Ophthalmol; 2009 Jun; 147(6):1109-10; author reply 1110. PubMed ID: 19463552 [No Abstract] [Full Text] [Related]
4. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Gueudry J; Wechsler B; Terrada C; Gendron G; Cassoux N; Fardeau C; Lehoang P; Piette JC; Bodaghi B Am J Ophthalmol; 2008 Dec; 146(6):837-44.e1. PubMed ID: 19027420 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation criteria for uveitis in Behçet's syndrome]. Hamza M; Ouertani A Rev Rhum Ed Fr; 1993 Apr; 60(4):315-6. PubMed ID: 8167635 [No Abstract] [Full Text] [Related]
6. Steroid therapy in uveitis. Coles RS Int Ophthalmol Clin; 1966; 6(4):869-901. PubMed ID: 4294917 [No Abstract] [Full Text] [Related]
7. Behçet disease-associated uveitis successfully treated with golimumab. Mesquida M; Victoria Hernández M; Llorenç V; Pelegrín L; Espinosa G; Dick AD; Adán A Ocul Immunol Inflamm; 2013 Apr; 21(2):160-2. PubMed ID: 23252659 [TBL] [Abstract][Full Text] [Related]
8. [Infliximab treatment for Behçet's disease--beginning of the biological drug era]. Namba K Nippon Ganka Gakkai Zasshi; 2010 Feb; 114(2):85-6. PubMed ID: 20187504 [No Abstract] [Full Text] [Related]
9. Is there a change of corneal thickness in uveitis with Behçet disease? Ozdamar Y; Berker N; Ertugrul G; Gurlevik U; Karakaya J; Ozkan SS Cornea; 2010 Nov; 29(11):1265-7. PubMed ID: 20802318 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab. Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069 [No Abstract] [Full Text] [Related]
11. Uveitis in juvenile Behçet's disease: clinical course and visual outcome compared with adult patients. Kramer M; Amer R; Mukamel M; Snir M; Jaouni T; Friling R Eye (Lond); 2009 Nov; 23(11):2034-41. PubMed ID: 19151650 [TBL] [Abstract][Full Text] [Related]
12. [Bolus of cyclophosphamide and methylprednisolone in uveitis in Behçet's disease. Preliminary results with the use of new criteria of evaluation]. Hamza M; Meddeb S; Mili I; Ouertani A Ann Med Interne (Paris); 1992; 143(7):438-41. PubMed ID: 1300863 [TBL] [Abstract][Full Text] [Related]
13. Clinical course and outcome of uveitis in children. Friling R; Kramer M; Snir M; Axer-Siegel R; Weinberger D; Mukamel M J AAPOS; 2005 Aug; 9(4):379-82. PubMed ID: 16102490 [TBL] [Abstract][Full Text] [Related]
14. Etiology of uveitis. Witmer R Ann Ophthalmol; 1972 Aug; 4(8):615-25. PubMed ID: 5065941 [No Abstract] [Full Text] [Related]
15. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients. Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907 [TBL] [Abstract][Full Text] [Related]
16. Acute coronary syndrome and Behçet's disease. Manfrini O; Xhyheri B; Pizzi C J Cardiovasc Med (Hagerstown); 2012 Jun; 13(6):401-2. PubMed ID: 22551691 [No Abstract] [Full Text] [Related]
17. Conjunctival ulcers in Behçet's disease. Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237 [TBL] [Abstract][Full Text] [Related]
18. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease. Park JY; Chung YR; Lee K; Song JH; Lee ES Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144 [TBL] [Abstract][Full Text] [Related]
19. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study. Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639 [TBL] [Abstract][Full Text] [Related]
20. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN. Kotter I; Deuter C; Stubiger N; Zierhut M J Rheumatol; 2005 Aug; 32(8):1633; author reply 1634. PubMed ID: 16078350 [No Abstract] [Full Text] [Related] [Next] [New Search]